Anticorps Recombinant de lapin anti-CD85j / LILRB1

CD85j / LILRB1 Recombinant Antibody for FC

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

FC

Conjugaison

CoraLite®594 Fluorescent Dye

CloneNo.

GHI/75

N° de cat : CL594-65623

Synonymes

LILRB1, CD85, CD85 antigen-like family member J, CD85j, FLJ37515



Applications testées

Résultats positifs en cytométrieCMSP humaines

Dilution recommandée

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, check data in validation data gallery

Informations sur le produit

CL594-65623 cible CD85j / LILRB1 dans les applications de FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Recombinant
Type Anticorps
Immunogène Human Hairy Cell Leukemia Spleen Cells
Nom complet leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
Masse moléculaire calculée 71 kDa
Numéro d’acquisition GenBankBC015731
Symbole du gène LILRB1
Identification du gène (NCBI) 10859
Conjugaison CoraLite®594 Fluorescent Dye
Excitation/Emission maxima wavelengths588 nm / 604 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide and 0.5% BSA
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

LILRB1, also named as CD85j or ILT2, includes four C2 Ig domains binding HLA class I molecules in the extracellular region and a cytoplasmic domain containing four immunoreceptor tyrosine-based inhibition motifs (ITIM). LILRB1 is a surface glycoprotein detected on the surface of B cells, monocytes, dendritic cells, T cells and NK cells.

Protocole

Product Specific Protocols
FC protocol for CL594 CD85j / LILRB1 antibody CL594-65623Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}